The Network of European CNS Transplantation and Restoration (NECTAR): An Introduction on the Occasion of its Tenth Meeting

Armstrong R. J. E. ; Svendsen C. N. Neural stem cells: From cell biology to cell replacement. Cell Transplant. 9: 139–152; 2000.

Backlund E-O. ; Granber P-O. ; Hamberger B. ; Sedvall G. ; Seiger A. ; Olson L. Transplantation of adrenal medullary tissue to striatum in parkinsonism: First clincal trials. J. Neurosurg. 62: 169–173; 1985.

Barker R. A. ; Kendall A. L. ; Widner H. ; Neural Tissue Xenografting Project. Neural tissue xenotransplantation: What is needed prior to clinical trials in Parkinson's disease? Cell Transplant. 9: 235–246; 2000.

Benazzouz A. ; Piallat B. ; Ni Z. G. ; Koudsie A. ; Pollak P. ; Benabid A. L. Implication of the subthalamic nucleus in the pathophysiology and pathogenesis of Parkinson's disease. Cell Transplant. 9: 215–221; 2000.

Blakemore W. F. ; Franklin R. J. M. Transplantation options for therapeutic central nervous system remyelination. Cell Transplant. 9: 289–294; 2000.

Blits B. ; Dijkhuizen P. A. ; Hermens W. T. J. M. C. ; Van Esseveldt K. E. ; Boer G. J. ; Verhaagen J. The use of adenoviral vectors and ex vivo transduced neurotransplants: Towards promotion of neuroregeneration. Cell Transplant. 9: 169–178; 2000.

Boer G. J. Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and research. J. Neurol. 242: 1–13; 1994.

Brundin P. ; Karlsson J. ; Emgård M. ; Kaminski Schierle G. S. ; Hansson O. ; Petersén Å. ; Castilho R. F. Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant. 9: 179–195; 2000.

Danielsen E. H. ; Cumming P. ; Andersen F. ; Bender D. ; Brevig T. ; Falborg L. ; Gee A. ; Gillings N. M. ; Hansen S. B. ; Hermansen F. ; Johansen J. ; Johansen T. E. ; Dahl-Jørgensen A. ; Jørgensen H. A. ; Meyer M. ; Munk O. ; Pedersen E. B. ; Poulsen P. H. ; Rodell A. B. ; Sakoh M. ; Simonsen C. Z. ; Smith D. F. ; Sørensen J. C. ; Østergård L. ; Zimmer J. ; Gjedde A. ; Møller A. The DaNeX study of embryonic mesencephalic, dopaminergic tissue grafted to a minipig model of Parkinson's disease: Preliminary findings of effect of MPTP poisoning on striatal dopaminergic markers. Cell Transplant. 9: 247–259; 2000.

Defer G. L. ; Geny C. ; Ricolfi F. ; Fenelon G. ; Monfort J. C. ; Remy P. ; Villafane G. ; Jeny P. ; Samson Y. ; Keravel Y. ; Gaston A. ; Degos J. D. ; Peschanski M. ; Cesaro P. ; Nguyen J. P. Long-term outcome of unilaterally transplanted Parkinsonian patients. I. Clinical approach. Brain 119: 41–50; 1996.

Defer G. L. ; Widner H. ; Marie R-M. ; Remy P. ; Levivier M. ; Conference Participants. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov. Disord. (in press).

Fahn S. ; Greene P. E. ; Tsai W-Y. ; Eidelberg D. E. ; Winfield H. ; Dillon S. ; Kao R. ; Winfield L. ; Breeze R. E. ; Freed C. R. Double-blind controlled trial of human embryonic dopaminergic tissue transplants in advanced Parkinson's disease: Clinical outcomes. Neurology 52: A405; 1999.

Fazzini E. ; Dwork A. J. ; Blum C. ; Burke R. ; Cote L. ; Goodman R. R. ; Jacobs T. P. ; Naini A. B. ; Pezzoli G. ; Pullman S. ; Solomon R. A. ; Truong D. ; Weber C. J. ; Fahn S. Stereotactic implantation of autologous adrenal medulla into caudate nucleus in four patients with parkinsonism. Arch. Neurol. 48: 813–820; 1991.

Fink J. S. ; Schumacher J. M. ; Ellias S. L. ; Palmer E. P. ; Saint-Hilaire M. ; Shannon K. ; Penn R. ; Starr P. ; VanHorne C. ; Kott H. S. ; Dempsey P. K. ; Fishman A. J. ; Raineri R. ; Manhart C. ; Dinsmore J. ; Isacson O. Porcine xenografts in Parkinson's disease and Huntington's disease patients: Preliminary results. Cell Transplant. 9: 273–278; 2000.

Freed C. R. ; Breeze R. E. ; Rosenberg N. L. ; Schneck S. A. ; Kriek E. ; Qi J-X. ; Lone T. ; Zhang Y-B. ; Snyder J. A. ; Wells T. H. ; Ramig L. O. ; Thompson L. ; Mazziotta J. C. ; Huang S. C. ; Grafton S. T. ; Brooks D. ; Sawle G. ; Schroter G. ; Ansari A. A. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N. Engl. J. Med. 327: 1549–1555; 1992.

Freeman T. B. ; Olanow C. W. ; Hauser R. A. ; Nauert G. M. ; Smith D. A. ; Borlongan C.V. ; Sanberg P. R. ; Holt D. A. ; Kordower J. H. ; Vingerhoets F. J. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol. 38: 379–388; 1995.

Gray J. A. ; Grigoryan G. ; Virley D. ; Patel S. ; Sinden J. D. ; Hodges H. Conditionally immortilized, multipotential and multifunctional neural stem cell lines as an approach to clinical transplantation. Cell Transplant. 9: 153–168; 2000.

Hauser R. A. ; Freeman T. B. ; Snow B. J. ; Nauert M. ; Gauger L. ; Kordower J. ; Olanow C. W. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson's disease. Arch. Neurol. 56: 179–187; 1999.

Hitchcock E. R. ; Kenny B. ; Clough C. G. ; Hughes R. C. ; Henderson B. T. H. ; Detta A. Stereotactic implantation of foetal mesencephalon (STIM): The UK experience. Prog. Brain Res. 82: 723–728; 1990.

Horvath M. ; Pasztor E. ; Palkovits M. ; Solyom A. ; Taczy M. ; Lekka N. ; Csanda E. Autotransplantation of superior cervical ganglion to the caudate nucleus in three patients with Parkinson's disease (preliminary report). Neursurg. Rev. 13: 119–122; 1990.

Kordower J. H. ; Freeman T. B. ; Chen E. Y. ; Mufson E. J. ; Sanberg P. R. ; Hauser R. A. ; Snow B. ; Olanow C. W. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov. Disord. 13: 383–393; 1998.

Langston J. W. ; Widner H. ; Goetz C. G. ; Brooks D. ; Fahn S. ; Freeman T. ; Watts R. Core assessment program for intracerebral transplantation (CAPIT). Mov. Disord. 7: 2–13; 1992.

Larsson L. C. ; Czech K. A. ; Brundin P. ; Widner H. Intrastriatal ventral mesencephalic xenografts of porcine tissue in rats: Immune responses and functional effects. Cell Transplant. 9: 261–272; 2000.

Levivier M. ; Dethy S. ; Rodesch F. ; Peschanski M. ; Vandesteene A. ; David P. ; Wikler D. ; Goldman S. ; Claes T. ; Biver F. ; Liesand C. ; Goldman M. ; Hildebrand J. ; Brotchi J. Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients. Stereotact. Funct. Neurosurg. 69: 99–111; 1997.

Lindvall O. ; Brundin P. ; Widner H. ; Rehncrona S. ; Gustavii B. ; Frackowiak R. ; Leenders K. L. ; Sawle G. ; Rothwell J. C. ; Marsden C. D. ; Björklund A. Grafts of fetal dopamine neurons survive and improve motor function on Parkinson's disease. Science 247: 574–577; 1990.

Lindvall O. ; Rehncrona S. ; Gustavii B. ; Brundin P. ; Astedt B. ; Widner H. ; Lindholm T. ; Björklund A. ; Leenders K. L. ; Rothwell J. C. Fetal dopamine-rich mesencephalic grafts in Parkinson's disease. Lancet 2: 1483–1484; 1988.

López-Lozano J. J. ; Bravo G. ; Brera B. ; Millan I. ; Dargallo J. ; Salmeán J. ; Uria J. ; Insausti J. Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. J. Neurosurg. 86: 931–940; 1997.

Madrazo I. ; Drucker-Colin R. ; Diaz V. ; Martinez-Mata J. ; Torres C. ; Becerril J. J. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N. Engl. J. Med. 316: 831–834; 1987.

Madrazo I. ; Leon V. ; Torres C. ; Aguilera M. C. ; Varela G. ; Alvarez F. ; Fraga A. ; Drucker-Colin R. ; Ostrosky F. ; Skurovich M. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. N. Engl. J. Med. 318: 51; 1988.

Madrazo I. ; Franco-Bourland M. ; Aguilera M. ; Ostrosky-Solis F. ; Cuevas C. ; Castregon H. ; Velazquez D. ; Grijalva E. ; Guizar-Sahagun G. ; Magallon E. ; Madrazo M. Fetal ventral mesencephalon brain homotransplantation in Parkinson's disease; the Mexican experience. Restor. Neurol. 4: 123–130; 1991.

Molina H. ; Quiñones R. ; Alvarez L. ; Galarraga J. ; Piedra J. ; Suárez C. ; Rachid M. ; García J. C. ; Perry T. L. ; Santana A. ; Carmenate H. ; Macías R. ; Torres O. ; Rojas M. J. ; Cordova F. ; Muñoz J. L. Transplantation of human fetal mesencephalic tissue in caudate nucleus as treatment for Parkinson's disease: The Cuban experience. Restor. Neurol. 4: 99–110; 1991.

Network of European CNS Transplantation and Restoration (NECTAR). Abstracts of the 10th NECTAR meeting, Amsterdam. Cell Transplant. 8; 1999.

Peschanski M. ; Cesaro P. ; Hantraye P. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 68: 273–285; 1995.

Peschanski M. ; Defer G. ; N'Guyen J. P. ; Ricolfi F. ; Monfort J. C. ; Remy P. ; Geny C. ; Samson Y. ; Hantraye P. ; Jeny R. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117: 487–499; 1994.

Quinn N. ; Brown R. ; Craufurd D. ; Goldman S. ; Hodges J. ; Kieburtz K. ; Lindvall O. ; MacMillan J. ; Roos R. Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD). Mov. Disord. 2: 143–150; 1996.

Rödter A. ; Winkler C. ; Samii M. ; Nikkhah G. Complex sensorimotor behavioral changes after terminal striatal 6-OHDA lesion and transplantation of dopaminergic embryonic micrografts. Cell Transplant. 9: 197–214; 2000.

Spencer D. D. ; Robbins R. J. ; Naftolin F. ; Marek K. L. ; Vollmer T. ; Leranth C. ; Roth R. H. ; Price L. H. ; Gjedde A. ; Bunney B. S. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N. Engl. J. Med. 327: 1541–1548; 1992.

Watts C. ; Dunnett S. B. Towards a protocol for the preparation and delivery of striatal tissue for clinical trials of transplantation in Huntington's disease. Cell Transplant. 9: 223–234; 2000.

Wenning G. K. ; Odin P. ; Morrish P. ; Rehncrona S. ; Widner H. ; Brundin P. ; Rothwell J. ; Brown R. ; Gustavii B. ; Hagell P. ; Jahanshahi M. ; Sawle G. ; Björklund A. ; Brooks D. ; Marsden C. D. ; Quinn N. P. ; Lindvall O. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42: 95–107; 1997.

Wenning G. K. ; Tison F. ; Scherfler C. ; Puschban Z. ; Waldner R. ; Granata R. ; Ghorayeb I. ; Poewe W. Towards neurotransplantation in multiple system atrophy: Clinical rationale, pathophysiological basis, and preliminary experimental evidence. Cell Transplant. 9: 279–288; 2000.

Widner H. ; Tetrud J. ; Rehncrona S. ; Snow B. ; Brundin P. ; Gustavii B. ; Björklund A. ; Lindvall O. ; Langston J. W. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N. Engl. J. Med. 237: 1556–1563; 1992.